izpis_h1_title_alt

Evolution of diabetes technology
ID Dovč, Klemen (Avtor), ID Battelino, Tadej (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (302,87 KB)
MD5: 314329F899C3B6B5067557D5A1E96A21
URLURL - Izvorni URL, za dostop obiščite https://www.sciencedirect.com/science/article/pii/S088985291930091X Povezava se odpre v novem oknu

Izvleček
In view of the current accelerating pace of diabetes technology development, ever smaller and more accurate CGM sensors, novel implantable sensors for long-term use (>1 year) with no on-body components, and CGM devices with increased connectivity and improved data visualization both on the device and remotely through the cloud can be anticipated. Automated systems for insulin delivery will become more independent and will likely incorporate other physiologic and behavioral data for providing more accurate predictions, particularly related to food and physical activity. With the increasing technical complexity, DSSs will become an inevitable part of digital diabetes clinics, including their use at the primary care level. In addition, all will depend on the cost-effectiveness that will drive the access and reimbursement of different technologies, and ultimately on the acceptance of any particular technology by individuals with diabetes. TIR is being validated as a new clinical marker, and simple clinical guidance on TIR targets and data visualization were broadly endorsed by professionals, and are being introduced to individuals with diabetes. However, the ultimate goal of diabetes technology development remains clear: improved diabetes outcomes with reduced disease burden and increased QOL for all individuals with diabetes and their families.

Jezik:Angleški jezik
Ključne besede:artificial pancreas, type 1 diabetes, continuous glucose monitoring, insulin pump, technology, closed loop, self-monitoring of blood glucose, multiple daily injections
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:MF - Medicinska fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2020
Št. strani:Str. 1-18
Številčenje:Vol. 50, iss. 1
PID:20.500.12556/RUL-137774 Povezava se odpre v novem oknu
UDK:616.379
ISSN pri članku:0889-8529
DOI:10.1016/j.ecl.2019.10.009 Povezava se odpre v novem oknu
COBISS.SI-ID:6802092 Povezava se odpre v novem oknu
Datum objave v RUL:30.06.2022
Število ogledov:424
Število prenosov:155
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Endocrinology and metabolism clinics of North America
Skrajšan naslov:Endocrinol. metab. clin. North Am.
Založnik:Elsevier
ISSN:0889-8529
COBISS.SI-ID:25392384 Povezava se odpre v novem oknu

Licence

Licenca:CC BY-NC-ND 4.0, Creative Commons Priznanje avtorstva-Nekomercialno-Brez predelav 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by-nc-nd/4.0/deed.sl
Opis:Najbolj omejujoča licenca Creative Commons. Uporabniki lahko prenesejo in delijo delo v nekomercialne namene in ga ne smejo uporabiti za nobene druge namene.

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj